|
" Anticancer agents : "
Iwao Ojima, Gregory D. Vite, Karl-Heinz Altmann, editor[s]
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
660533
|
| Doc. No
|
:
|
dltt
|
| Title & Author
|
:
|
Anticancer agents : : frontiers in cancer chemotherapy /\ Iwao Ojima, Gregory D. Vite, Karl-Heinz Altmann, editor[s]
|
| Series Statement
|
:
|
ACS symposium series;; 796
|
| Page. NO
|
:
|
xii, 364 pages :: illustrations ;; 24 cm
|
| ISBN
|
:
|
084123745X
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and indexes
|
| Contents
|
:
|
Cancer drug discovery and development : new paradigms for a new millennium / E.A. Sausville ... [et al.] -- Evolutionary biosynthesis of anticancer drugs / George R. Pettit -- Some recent developments in the synthesis and structure-activity relationship of novel taxanes / John F. Kadow ... [et al.] -- New generation taxoids and hybrids of microtubule-stabilizing anticancer agents / Iwao Ojima ... [et al.] -- Discodermolide and taxol : a synergistic drug combination in human carcinoma cell lines / Susan Band Horwitz ... [et al.] -- Highly efficient semisynthesis of biologically active epothilone derivatives / Gregory D. Vite ... [et al.] -- Synthetic and semisynthetic analogs of epothilones : chemistry and biological activity / Karl-Heinz Altmann ... [et al.] -- Synthesis and biological activity of epothilones / Ulrich Klar ... [et al.] -- Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou -- Synthesis and structure-activity relationship studies of cryptophycins : a novel class of potent antimitotic antitumor depsipeptides / Chuan Shih ... [et al.] -- Farnesyltransferase inhibitors as potential anticancer agents / J.B. Gibbs ... [et al.] -- Farnesyltransferase inhibitors : from squalene synthase inhibitors to the clinical agent BMS-214662 / John T. Hunt -- Inhibiting farnesyl protein transferase with Sch-66336 : potentially a selective noncytotoxic therapy for human cancer / A.G. Taveras ... [et al.] -- Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.] -- STI571 : a new treatment modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger -- The discovery and development of second-generation matrix metalloproteinase inhibitors for the treatment of cancer / Andy Baxter and John Montana -- Prospects for antiangiogenic therapies based upon VEGF inhibition / Pascal Furet and Paul W. Manley -- Carbohydrate-based tumor antigens as antitumor vaccine agents / Jennifer R. Allen and Samuel J. Danishefsky -- Drugs to enhance the therapeutic potency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari
|
| Subject
|
:
|
Antineoplastic agents, Congresses
|
| Subject
|
:
|
Antineoplastic Agents-- therapeutic use
|
| Subject
|
:
|
Neoplasms-- drug therapy
|
| Dewey Classification
|
:
|
616.99/4061
|
| LC Classification
|
:
|
RS431.A64A56 2001
|
| NLM classification
|
:
|
2002 E-459
|
|
|
:
|
QZ 267A6285 2001
|
| Added Entry
|
:
|
Ojima, Iwao,1945-
|
|
|
:
|
Vite, Gregory D
|
|
|
:
|
Altmann, Karl-Heinz
|
| Added Entry
|
:
|
American Chemical Society., Division of Organic Chemistry
|
|
|
:
|
American Chemical Society., Division of Medicinal Chemistry
|
|
|
:
|
American Chemical Society., Meeting(219th :2000 :, San Francisco, Calif.)
|
| |